Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report released on Sunday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of AMPE opened at $0.00 on Friday. The firm has a market capitalization of $570.00, a P/E ratio of 0.00 and a beta of 3.71. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $2.47. The firm has a fifty day moving average price of $0.02 and a 200-day moving average price of $0.01.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.